Espinoza S - Search Results

1

Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists.

Chiellini G, Nesi G, Digiacomo M, Malvasi R, Espinoza S, Sabatini M, Frascarelli S, Laurino A, Cichero E, Macchia M, Gainetdinov RR, Fossa P, Raimondi L, Zucchi R, Rapposelli S. Chiellini G, et al. Among authors: espinoza s. J Med Chem. 2015 Jun 25;58(12):5096-107. doi: 10.1021/acs.jmedchem.5b00526. Epub 2015 Jun 5. J Med Chem. 2015. PMID: 26010728

2

The dopamine metabolite 3-methoxytyramine is a neuromodulator.

Sotnikova TD, Beaulieu JM, Espinoza S, Masri B, Zhang X, Salahpour A, Barak LS, Caron MG, Gainetdinov RR. Sotnikova TD, et al. Among authors: espinoza s. PLoS One. 2010 Oct 18;5(10):e13452. doi: 10.1371/journal.pone.0013452. PLoS One. 2010. PMID: 20976142 Free PMC article.

3

Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor.

Espinoza S, Salahpour A, Masri B, Sotnikova TD, Messa M, Barak LS, Caron MG, Gainetdinov RR. Espinoza S, et al. Mol Pharmacol. 2011 Sep;80(3):416-25. doi: 10.1124/mol.111.073304. Epub 2011 Jun 13. Mol Pharmacol. 2011. PMID: 21670104 Free PMC article.

4

The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment.

Managò F, Espinoza S, Salahpour A, Sotnikova TD, Caron MG, Premont RT, Gainetdinov RR. Managò F, et al. Among authors: espinoza s. Sci Rep. 2012;2:301. doi: 10.1038/srep00301. Epub 2012 Mar 5. Sci Rep. 2012. PMID: 22393477 Free PMC article.

5

Role of catechol-O-methyltransferase (COMT)-dependent processes in Parkinson's disease and L-DOPA treatment.

Espinoza S, Manago F, Leo D, Sotnikova TD, Gainetdinov RR. Espinoza S, et al. CNS Neurol Disord Drug Targets. 2012 May;11(3):251-63. doi: 10.2174/187152712800672436. CNS Neurol Disord Drug Targets. 2012. PMID: 22483291 Review.

6

Insights into the structure and pharmacology of the human trace amine-associated receptor 1 (hTAAR1): homology modelling and docking studies.

Cichero E, Espinoza S, Gainetdinov RR, Brasili L, Fossa P. Cichero E, et al. Among authors: espinoza s. Chem Biol Drug Des. 2013 Apr;81(4):509-16. doi: 10.1111/cbdd.12018. Chem Biol Drug Des. 2013. PMID: 22883051

7

BRET biosensors to study GPCR biology, pharmacology, and signal transduction.

Salahpour A, Espinoza S, Masri B, Lam V, Barak LS, Gainetdinov RR. Salahpour A, et al. Among authors: espinoza s. Front Endocrinol (Lausanne). 2012 Aug 29;3:105. doi: 10.3389/fendo.2012.00105. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 22952466 Free PMC article.

8

BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling.

Espinoza S, Masri B, Salahpour A, Gainetdinov RR. Espinoza S, et al. Methods Mol Biol. 2013;964:107-22. doi: 10.1007/978-1-62703-251-3_8. Methods Mol Biol. 2013. PMID: 23296781

9

Long-term optical stimulation of channelrhodopsin-expressing neurons to study network plasticity.

Lignani G, Ferrea E, Difato F, Amarù J, Ferroni E, Lugarà E, Espinoza S, Gainetdinov RR, Baldelli P, Benfenati F. Lignani G, et al. Among authors: espinoza s. Front Mol Neurosci. 2013 Aug 20;6:22. doi: 10.3389/fnmol.2013.00022. eCollection 2013. Front Mol Neurosci. 2013. PMID: 23970852 Free PMC article.

10

Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.

Leo D, Mus L, Espinoza S, Hoener MC, Sotnikova TD, Gainetdinov RR. Leo D, et al. Among authors: espinoza s. Neuropharmacology. 2014 Jun;81:283-91. doi: 10.1016/j.neuropharm.2014.02.007. Epub 2014 Feb 22. Neuropharmacology. 2014. PMID: 24565640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters